Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 175 publications
MAGIC Composite Score Predicts Outcomes of Second-Line Therapy for Acute GVHD.
Journal: medRxiv : the preprint server for health sciences
Published: July 29, 2026
Reduced-Dose Post-Transplant Cyclophosphamide (PTCy 40-40) in Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: May 26, 2026
Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 30, 2026
Clinical Management of Acute Graft-Versus-Host Disease: An Evidence-Based Review from the ASTCT Committee on Practice Guidelines.
Journal: Transplantation and cellular therapy
Published: April 29, 2026
Belumosudil achieves clinical response in chronic graft-versus-host disease with varying organ-specific response kinetics: an analysis from the phase II ROCKstar trial.
Journal: Haematologica
Published: April 09, 2026
Incidence of and Risk Factors for Delayed Engraftment after Post-Transplant Cyclophosphamide.
Journal: Transplantation and cellular therapy
Published: December 15, 2025
eGFR Discordance and Its Association with Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation and Adoptive T-Cell Therapies.
Journal: Journal of the American Society of Nephrology : JASN
Published: November 20, 2025
Early safety of ruxolitinib as part of GVHD prophylaxis in mismatched unrelated donor HCT.
Journal: Bone marrow transplantation
Published: October 16, 2025
A Virtual Reality Psychosocial Intervention for Patients Undergoing Bone Marrow Transplantation (BMT-VR): Pilot Randomized Clinical Trial.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: September 24, 2025
Safe and Effective Addition of Ruxolitinib to Graft-versus-host Prophylaxis in Older Adults Undergoing Reduced-intensity Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: July 08, 2025
Multisite Randomized Trial of Inpatient Palliative Care Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 23, 2025
Last Updated: 09/26/2026